Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hepatitis × Mycophenolic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 117 Precursor Cell Lymphoblastic Leukemia-Lymphoma 103 Myelodysplastic Syndromes 97 Leukemia, Lymphocytic, Chronic, B-Cell 89 Lymphoma, Non-Hodgkin 87 Hodgkin Disease 81 Leukemia 75 Multiple Myeloma 72 Lymphoma 61 Lymphoma, Mantle-Cell 60 Lymphoma, Follicular 59 Lymphoma, Large B-Cell, Diffuse 57 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 54 Lymphoma, B-Cell, Marginal Zone 52 Myeloproliferative Disorders 50 Burkitt Lymphoma 48 Leukemia, Myelomonocytic, Chronic 45 Congenital Abnormalities 43 Lymphoma, Large-Cell, Immunoblastic 42 Leukemia, Myeloid, Chronic-Phase 42 Leukemia, Myeloid, Accelerated Phase 38 Hematologic Neoplasms 36 Anemia, Refractory, with Excess of Blasts 34 Primary Myelofibrosis 33 Graft vs Host Disease 32 Waldenstrom Macroglobulinemia 30 Blast Crisis 30 Dendritic Cell Sarcoma, Interdigitating 29 Recurrence 27 Neoplasms, Plasma Cell 27

Interventions

Blood Specimen Collection 2 bavituximab 1 Ursodeoxycholic Acid 1 Surveys and Questionnaires 1 Steroids 1 Spermine Synthase 1 Sorafenib 1 Sofosbuvir 1 Ribavirin 1 Prednisone 1 Phlebotomy 1 Mycophenolic Acid 1 Methylprednisolone Hemisuccinate 1 Methylprednisolone 1 Liquid Biopsy 1 Clinical Protocols 1 Adrenal Cortex Hormones 1 3-(2-(2-tert-butylphenylaminooxalyl)aminopropionylamino)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04810156 2022-12-14

I-HEP

Herlev Hospital

Phase 2 Unknown

Hepatitis, Neoplasms, Chemical and Drug Induced Liver Injury

Data powered by HemOnc (CC BY 4.0) Colophon ⚡